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Abstract: Immunosensors are analytical platforms that detect specific antigen-antibody interactions
and play an important role in a wide range of applications in biomedical clinical diagnosis, food safety,
and monitoring contaminants in the environment. Field-effect transistors (FET) immunosensors have
been developed as promising alternatives to conventional immunoassays, which require complicated
processes and long-time data acquisition. The electrical signal of FET-based immunosensors is
generated as a result of the antigen-antibody conjugation. FET biosensors present real-time and rapid
response, require small sample volume, and exhibit higher sensitivity and selectivity. This review
brings an overview on the recent literature of FET-based immunosensors, highlighting a diversity of
nanomaterials modified with specific receptors as immunosensing platforms for the ultrasensitive
detection of various biomolecules.
Keywords: biosensors; immunosensors; field-effect transistors; immunoFET; antigen-antibody;
nanomaterials
1. Introduction to Immunosensors
Biosensors are defined as analytical devices combining functional materials or biological elements
for the selective detection of an analyte. The recognition system consists of biological receptors,
for instance: enzymes, cellular receptors, antibodies, nucleic acids, microorganisms, or artificial
biomimetic materials, all equipped with biochemical mechanisms for recognition. Moreover, these
biodevices are capable of providing quantitative or semi-quantitative analytical information by forming
specific biological recognition complexes such as enzyme-substrate, antigen-antibody, etc., which are
able to convert the biochemical changes into a measurable signal by means of a physicochemical
transducer system [1,2]. Immunosensors are biosensors that detect either the sensitive biological
elements antibodies or antigens through the event of formation of specific antigen-antibody complexes.
The detection of antibodies is preferred and these biological elements are often properly immobilized
on the surface of the transducer [3].
An antibody (Figure 1, top-left inset) is a large protein in a “Y” shape that consists of highly ordered
sequences of hundreds of amino acids. Specifically, the antibody molecule structure is composed of
two heavy polypeptide chains (molecular weights of 50 kDa) and two light chains (molecular weights
of 25 kDa) linked by disulfide bonds. The chains have both constant and variable regions and the
antigen-binding takes place at light and heavy variable domains, forming the hyper-variable regions
of the antibody, known as the complementarity determining regions (CDR). The constant region is
generally preserved from one antibody to another class, while the CDR show a great diversity of
sequences [4,5].
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Figure 1. Scheme outlining an immunoFET operating in solution. Top-left inset represents an 
antibody structure, which is basically composed of two light and two heavy chains linked by disulfide 
bonds (red lines). Nanomaterials are embedded on the gate region as the semiconductor channel of a 
FET-based biosensor. Specific antibodies for antigen recognition are immobilized on the nanomaterial 
surface. The binding of positively charged target molecules on a p-type channel causes depletion of 
charge carriers (holes) and decrease in conductance, while in an n-type channel, the positively 
charged molecules result in accumulation of charge carriers (electrons) and increase in conductance.  
Antibodies are glycoproteins produced by the immune system to identify and neutralize foreign 
substances to the body, known as antigens. Antigens are molecules or particles capable of initiating 
an immune response, therefore triggering the production of antibodies. The antibodies, in turn, 
identify and bind to antigens with extremely high specificity, and a minor change in the chemical 
structure of an antigen can dramatically reduce its affinity for an antibody. Thus, the antibody must be 
specific, have a stable and strong interaction with the antigen, and be able to detect the target analyte at 
the required concentration range, ensuring the sensitivity and reliability of an immunosensor [5–8].  
Polyclonal antibodies are generated by multiple immune cells and can bind to the antigen target 
through a large number of epitopes (specific antigen regions where antibodies bind). Polyclonal 
antibodies are cheap and facile to produce, however they lack specificity. Monoclonal antibodies are 
produced from immune cells identical to the parent cells and recognize specific epitopes of an antigen, 
thus conferring higher selectivity than polyclonal. There is a plethora of commercially available 
antibodies and their production is generally mediated by immunizing an animal with a foreign 
infection to produce an immune response [5,9]. 
Immunosensors may be useful to monitor and quantify the functioning of the immune system, 
detecting the presence of specific antibodies or antigens in body fluids; therefore, they can be considered 
as promising tools in clinical diagnosis applications. The analytes may also include microorganisms 
such as viruses and bacteria, which find an important role in food safety, and pollutants such as 
pesticides and herbicides, that are valuable in environmental monitoring.  
Immunosensors can be divided in two groups: labeled and label-free. The labeled immunosensors 
are designed in a way that the immunoreaction is measured through the detection of the labeling of 
a molecule with labels such as luminescent, fluorescent, radioactive, and epitope tags [3]. For example, 
the most utilized enzyme immunoassay in clinical analysis and residual analysis in environmental and 
food samples is the label-based enzyme-linked immunosorbent assay (ELISA) [10]. The ELISA test 
basically consists of translating the recognition event between a specific enzyme-labeled antibody 
Figure 1. Scheme outlining a immunoFET operating i soluti n. Top-left inset represent an antibody
structure, which is basically composed of two light and two heavy chains linked by disulfi e bonds (red
lines). Nanomaterials are e bedded on the gate region as the semiconductor channel of a FET-based
biosensor. Specific antibodies for antigen recognition are immobilized on the nanomaterial surface.
The binding of positively charged target molecules on a p-type channel causes depletion of charge
carriers (holes) and decrease in conductance, while in an n-type channel, the positively charged
molecules result in accumulation of charge carriers (electrons) and increase in conductance.
Antibodies are glycoproteins produced by the immune syst m to identify nd neutralize foreign
substances to the body, known as antigens. Antigens are molecules or particles capable of initiating an
immune response, therefore triggering the production of antibodies. The antibodies, in turn, identify
and bind to antigens with extremely high specificity, and a minor change in the chemical structure of
an antigen can dramatically reduce its affinity for an antibody. Thus, the antibody must be specific,
have a stable and strong interaction with the antigen, and be able to detect the target analyte at the
required concentration range, ensuring the sensitivity and reliability of an immunosensor [5–8].
Polyclonal antibodies are generate by multiple immune cells and can bind to the antigen target
through a large nu ber of epitopes (specific antig n regions wh re antibodies bind). Polyclonal
antibodies are cheap and facile to produce, however t y lack s cificity. Monoclonal antibodi s are
produced from immune cells identical to the parent cells and recognize specific epitopes of an antigen,
thus conferring higher selectivity than polyclonal. There is a plethora of commercially available
antibodies and their production is generally mediated by immunizing an animal with a foreign
infection to produce an immune response [5,9].
Immunosensors may be useful to monitor and quantify the functioning of the immune system,
detecting the presence of specific antibodies or antigens in body fluids; therefore, they can be considered
as promising to ls in clinical diagnosis applications. The a alytes may also include icroorganisms
such as viruses a d b cteria, which find n import nt role in food saf ty, a d pollutants such as
pesticides and herbicide , that are valuable in environmental monitoring.
Immunosensors can be divided in two groups: labeled and label-free. The labeled i munosensors
are designed in a way that the immunoreaction is measured through the detection of the labeling of a
molecule with labels such as luminescent, fluorescent, radioactive, and epitope tags [3]. For example,
the most utilized enzyme immunoassay in clinical analysis and residual analysis in environmental and
food samples is the label-based enzyme-linked immunosorbent assay (ELISA) [10]. The ELISA test
basically consists of translating the recognition event between a specific enzyme-labeled antibody and
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an antigen into a colorimetric, chemiluminescent, or electrochemical signal [11,12]. Radioimmunoassay
(RIA) is also used in clinical diagnosis and involves the use of radiolabeled antigens or antibodies [13].
Despite the reliability and high sensitivity of conventional immunoassays, they suffer from drawbacks
such as the demand for relatively large volumes of sample, long incubation periods, complicated
laboratory apparatus, needing to be carried out by highly trained laboratory staff, and requiring
multiple labeling strategies that would not interfere with the antigen-antibody interactions [5].
On the other hand, the label-free immunosensors allow the direct monitoring of immunoreactions by
measuring physicochemical changes induced by the antigen-antibody complex formation, being more
attractive as alternatives amongst traditional immunoassays.
The transduction platforms convert the chemical or physical changes induced by selective
antigen-antibody interactions into a quantifiable signal. Signal transducing can be performed by
different transducing mechanisms. The most employed transducers in immunosensors are related
to the measurement of electrons, photons, and masses, thus including electrochemical, optical, and
piezoelectric systems, respectively. Biodevices based on electrochemical transducing platforms are the
most exploited so far because of their simple principle of measurement. The antigen-antibody complex
formation generates an electrical signal that can be measured by different means. In general terms,
electrochemical transducers comprise: amperometric/voltammetric, conductimetric, potentiometric,
impedance, and semiconductor field-effect principles; which measure changes in: current, modulation
of conductance, potential or charge accumulation, electrical impedance, and either the current or the
potential across a semiconductor in response of a binding process at the gate surface, respectively [9].
The optical transducers operate by means of an optical signal (color or fluorescence) or changes
in optical properties such as absorption, reflectance, emission, etc. promoted by the biorecognition
event. Lastly, piezoelectric transducers detect a mass increase induced by the antigen-antibody
complex, which can be detectable by piezoelectric devices such as a quartz crystal balance or a
microcantilever [2,14].
Although there are many kinds of transducing mechanisms, this review is concerned
with immunosensors whose transducing system is based on the field-effect transistors (FET).
Such transducers are considered charge-sensitive devices and present several associated advantages
such as excellent sensitivity and selectivity, label-free detection, real-time response, cost-effective
fabrication, and ease of miniaturization and integration in electronic chips, making them excellent
interfaces towards point-of-care (PoC) systems, as well as reusable and portable immunosensing
devices. The focus of this review is the description of recent developments and current trends in
FET-based immunosensors using nanomaterials as sensing platforms for different application fields.
For a more thorough comprehension, we refer to several reviews on immunosensor principles [3,5,14],
antibody engineering [4,6], transduction systems in immunosensing [5,14–16], basic mechanisms of
FET sensors [17], and FET-based biosensors [18,19].
2. FET-Based Immunosensors
FET-based sensors have been exploited for decades since the first reports on ion-sensitive field
effect transistors (ISFET) by Bergveld et al. [20–23]. FET-based biosensors operate by means of an
electrical field modulating charge carriers across a semiconductor material. Such sensors are able to
directly convert specific biological interactions into electrical signals. In the standard configuration
of a FET, the electric current flows along a semiconductor channel connected to the source and drain
electrodes. A third electrode, the gate contact, which is capacitively coupled to the device through a
thin dielectric layer (typically SiO2), modulates the conductance between these two electrodes [20,24].
A FET-based sensor detects potential changes on its gate surface. The FET device characteristics
can be assessed by the transfer curve, which is the plot of the current across drain-source electrodes (IDS)
as a function of the gate voltage (VG) at a constant drain-source voltage (VDS) [25–27]. A FET-based
biosensor usually operates in solution. In this case, the conductance between source and drain
electrodes is modulated by a gate voltage applied in the electrolyte solution by means of a reference
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electrode placed on the top of the channel. In this configuration, the surface charge in an electrolyte
attracts counter-ions forming the electric double layer (Debye layer) [26,28].
The semiconductor determines the type of charge carriers that can accumulate or deplete in the
channel, thus the current flow can either be the result of movement of holes (“p-type”) or electrons
(“n-type”). For example, the application of positive voltage on the gate of a p-type channel FET results
in depletion of charge carriers and a decrease in conductivity, whereas the application of negative
voltage leads to accumulation of charge carriers and an increase in conductivity [28,29]. There is a
great diversity of FET biosensors but we focus in this review on the FET-based immunosensors, whose
concept was introduced by Shenck in 1978 [30]. In an immunoFET, which is shown schematically in
Figure 1, the gate region is biofunctionalized by immobilizing antibodies or antigens on its surface,
allowing direct analyte-binding upon the device surface. Since antibodies and antigens are mostly
charged molecules, the biorecognition event imparts an electrical field, which modulates the charge
carrier flow between source and gate, generating an electrically detectable signal [31,32]. Thus, the
changes in conductance induced by the antigen-antibody binding can be measured and correlated to
the analyte concentration [33].
ImmunoFET features simplicity of use and production, portability, high sensitivity (detecting
picomolar and femtomolar levels of an analyte), utilizes a small volume of sample (in the microliters
range), has low operating costs, and enables real-time analyte detection and quantification [34].
The exquisite sensibility of immunoFET is due to the fact that these sensors act as a combination of a
sensor and an amplifier, in which the biorecognition channel is in direct contact with the analyte and
the occurrence of only a single biological event is capable of causing a pronounced current change in
the sensing channel [35,36].
Under ideal conditions, an immunoFET is able to detect target biomolecules in biochemically or
clinically meaningful range of concentrations, which can vary in the order of sub-fM to µM, achieving
very low detection limits. Ideal conditions include full antibody coverage, capacitive interface, highly
charged antigens, and low ionic strength buffers [18]. However, in real conditions, samples contain
rich levels of salts and species of non-interest. Therefore, these immunosensors present practical issues
in transducing the antigen-antibody immunoreaction into a measurable signal and the direct sensing
has proven to be challenging [37].
It was argued that an immunoFET is able to detect only charge or potential changes occurring
within the Debye layer [21]. According to the Debye theory, an increase in ion concentration reduces
the Debye length due to charge screening by counter-ions [38]. Thus, the Debye screening length,
which is a physical distance where the charged analyte is electrically screened by the ions in the
medium, strongly affects the immunosensor sensitivity in high ionic strength buffers. The Debye
length (λD) in an electrolyte is given by the following equation [39]:
λD =
√
ε0 εr kB T
2 NAq2 I
, (1)
where ε0 corresponds to the vacuum permittivity; εr is the relative permittivity of the medium; kB is
the Boltzmann constant; T is the absolute temperature; NA is the Avogadro number; q is the charge on
an electron; and I is the ionic strength of the solution.
Therefore, λD is dependent on the ionic strength of the electrolytic buffer solution. To summarize,
it decreases as the ionic strength increases, and a short Debye length implies a lower sensitivity
because the FET sensor cannot detect the analyte-binding beyond the Debye length, as illustrated
in Figure 2a. For instance, in a physiological solution (biological fluids such as blood, serum, urine,
etc.) or undiluted phosphate-buffered saline solution (PBS buffer, ion concentration of 0.15 M), the
dimensions of some antibodies (10–12 nm) are large enough to surpass the thickness of the Debye
length (~0.8 nm) at the electrolyte-immunosensor interface. In this case, the analyte charges will be
at a farther distance from the surface than the Debye length and will be shielded from the sensing
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channel by buffer counter-ions [17,40]. However, the poor sensitivity caused by the enlargement of the
Debye layer can be overcome by pretreating the analyte solution, which may include conditioning
steps of centrifugation, filtration, and dilution to low ionic strength (ion concentration lower than
10−2–10−3 M) prior to analysis [41], and then a measurable effect by an immunoFET can be observed.
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Figure 2. Antibodies (Y shape) immobilized on the gate region. Antigens (spheres) are bound to 
antibodies and the dashed lines indicate the Debye length position. (a) The Debye length is dependent 
on the ionic strength of the electrolytic buffer and it increases with the reduction of solution ionic 
strength. A measurable analyte-binding may occur only within the Debye length; (b,c) show 
alternative methods for antigen detection in high ionic strength solutions, without sample desalting; 
(b) (i) the antibody was cleaved by enzymatic digestion; and (ii) the antigen was brought within the 
Debye length [40]; (c) a more realistic representation of antibody alignment on the surface of an 
immunoFET showing random orientation of antibodies relative to the sensing surface, implying that 
some analyte-binding may occur within the Debye length [42]. 
The classical assessment described above evidences the dependence on proximity of the analyte 
to the device surface for an immunoFET proper function [19–23,43]. However, conceptual flaws 
concerning this model have been revised. In this context, Elnathan et al. demonstrated the direct 
detection of cardiac troponin I (cTnI) myocardial infarction biomarker without the need for sample 
desalting by bringing the antigen within the Debye length [40]. Their approach was based on 
fragmentation of antibody units, allowing the biorecognition event to occur in closer proximity to the 
silicon nanowire (SiNW) sensing surface, and consequently within the Debye screening length 
(Figure 2b). The authors cleaved antibodies by enzymatic digestion in order to remove parts that 
were not required for the antigen-binding and the fragments were able to directly detect cTnI with a 
sensitivity limit down to pM, without the need of biosample desalting. Casal et al. discussed that 
antibodies were highly flexible structures that can adsorb to surfaces via a nearly random distribution 
of their structural domains, and can also be variably oriented in relation to the surface [42]. Therefore, 
the analytes can bind to antibodies in a distribution of orientations and distances from the sensing 
surface, implying that some analyte charges would be held within the Debye length, and consequently, 
the analyte should be detected by the immunoFET even in a high ionic strength condition (Figure 2c). 
The authors supported their assumption demonstrating multiple immunoFETs able to detect human 
and murine chemokines in physiologically relevant high ionic strength buffers [42]. 
  
Figure 2. Antibodies (Y shape) immobilized on the gate region. Antigens (spheres) are bound
to antibodies and the dashed lines indicate the Debye length position. (a) The Debye length is
dependent on the ionic strength of the electrolytic buffer and it increases with the reduction of solution
ionic strength. A measurable analyte-binding may occur only within the Debye length; (b,c) show
alternative methods for antigen detection in high ionic strength solutions, without sample desalting;
(b) (i) the antibody was cleaved by enzymatic digestion; and (ii) the antige was brought within
the Debye length [40]; (c) m re realistic representation of antibody alig ment on the surface of an
immunoFET showi g random orientation of antibodies relative to the sensing surface, implying that
some analyte-binding may occur within the Debye length [42].
The classical assessment described above evidences the dependence on proximity of the analyte
to the device surface for an immunoFET proper function [19–23,43]. However, conceptual flaws
concerning this model have been revised. In this context, Elnathan t al. demonstrated the direct
detection of c rdiac troponin I (cTnI) myocardial infarc biomarker without the need for sample
desalting by bringing the antige within the Deby length [40]. T eir approach was based on
fragmentation of antibody units, allowing the biorecognition event to occur in closer proximity
to the silicon nanowire (SiNW) sensing surface, and consequently within the Debye screening length
(Figure 2b). The authors cleaved antibodies by enzymatic digestion in order to remove parts that
were not required for the antigen-binding and the fragments were able to directly detect cTnI with
a sensitivity limit down to pM, without the need of biosample desalting. Casal et al. discussed that
antibodies were highly flexible structures that can adsorb to surfaces via a nearly random distribution
of their structural domains, and can also be variably orie ted in relation to t e surface [42]. Therefore,
the analytes can bind to antibodies in a distribution of orientat ons and di tances from t e se sing
surface, i plying that some anal te charges would be held withi the Debye length, and consequently,
the analyte should be detected by the immunoFET even in a high ionic strength condition (Figure 2c).
The authors supported their assumption demonstrating multiple immunoFETs able to detect human
and murine chemokines in physiologically relevant high ionic strength buffers [42].
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3. Trends in FET-Based Immunosensors Using Nanomaterials as Sensing Platforms
Nanostructured materials have attracted a great deal of attention in their application for
developing novel FET-based biosensing devices with enhanced sensibility and selectivity [5,34,44].
Owing to nanoscale dimensions (1–100 nm), nanomaterials exhibit tunable and unique physicochemical
properties which are not observed in their bulk counterparts, including high specific surface area, high
aspect ratio, increased chemical and thermal stability, and remarkable electrical properties. In addition,
various biocompatible nanomaterials have their dimensions comparable to a range of biomolecules,
facilitating their use for immunocompounds immobilization.
Nanomaterials are capable of modifying the exposed gate region of FET-based immunosensors,
thus improving the immobilization of bioreceptors and the signal transducing [44]. Properties like
the high aspect ratio allow the atoms to be located at or close to the gate surface, and as the biological
recognition is related to the physical signal across the whole device, the device sensitivity is improved
as a result of the increased surface-to-volume ratio. In addition, some nanomaterials can easily be
chemically modified with specific sensing elements. Therefore, the use of nanomaterials as sensing
platforms offers excellent interface perspectives for biological recognition, facilitating the attachment of
biomolecules and allowing the scaling of microelectronics down to the nano level, which consequently
enables the design of immunosensors with enhanced performance.
Recently, an increasing number of immunosensors using nanomaterials such as carbon nanotubes,
graphene, nanowires, metal and metal oxide, and nanohybrids as semiconducting channel have been
reported [44–46]. In this review, we highlight recent advances on the incorporation of nanomaterials on
the gate surface of FET-based immunosensors applied to biomedical clinical diagnosis, environmental
monitoring, and food safety fields. We consider the most important semiconducting nanomaterials
for immunosensing purpose over the past five years. Selected reports outlining the exploitation of
these nanomaterials in composing the sensing platform of FET immunosensors are discussed in the
following sections.
Tables 1 and 2 assess the successful application of various types of nanomaterials in the fabrication
of FET-based immunosensors. Recent reports were carefully examined on the basis of target analyte,
electroactive nanomaterial, range of concentrations, and detection limit. Table 1 shows several
FET immunosensors relevant to clinical biomedical diagnosis. It is evident that a great diversity
of disease biomarkers can be detected through immunoFET devices, opening new paths for early-stage
diagnosis of serious diseases such as cancer. For instance, prostate specific antigen (PSA), a prostate
cancer biomarker, was ultrasensitively detected by using immunoFET devices based on different
nanomaterials such as silicon nanowires (SiNW) [47,48], graphene [49], molybdenum disulfide
(MoS2) [50,51], etc. The lowest detection limit of PSA was achieved by a FET device based on SiNW
(1 fg·mL−1) [47]. Detection of tumor biomarkers for breast cancer [52,53], hepatic carcinoma [54], oral
squamous cell carcinoma [55], pancreatic cancer [56], and bladder cancer [57] have also been reported.
Moreover, other disease biomarkers related to cardiovascular diseases [58–60], thyroid hormone [61],
venous thromboembolism [62], Alzheimer [63], and diabetes [64,65] have been detected with very low
detection limits.
Table 2 evidences the ultrasensitive detection of pathogenic microorganisms associated with human
health and food safety, such as Salmonella [66,67] and Escherichia coli [68–71] bacteria, rotavirus [72] and
bacteriophage [69] viruses, and parasitic protozoan [73]. For example, graphene-based FET devices
were found to detect only 10 colony-forming units per milliliter (CFU·mL−1) of E. coli bacteria [68,70]
whereas a cerium oxide (CeOx)-based FET device was able to achieve a limit of detection (LOD) as low
as 2–3 cells of Salmonella typhimurium per mL [67]. Table 2 also depicts the application of immunoFET
devices for detecting environmental contaminants such as pesticides [74], herbicides [75], toxins [76],
and phytopathogens [77].
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Table 1. Recent reports on immunoFET sensors based on various types of nanomaterials applied to clinical biomedical diagnosis.
Target Analyte Electroactive Nanomaterial Range Detection Limit Reference
–H5N2 avian influenza virus SiNW 10−17–10−12 M 10−17 M [78]
Hepatitis B marker (HBsAg) and cancer marker α-fetoprotein (AFP) SiNW - 10
−14 M for HBsAg and 10−15 M
for AFP
[79]
Human thyroid stimulating hormone SiNW 0.02–30 mIU·L−1 0.02 mIU·L−1 [61]
Biomarkers of oral squamous cell carcinoma Interleukin-8 (IL-8) and
tumor necrosis factor α (TNF-α) SiNW 1 fg·mL
−1–1 ng·mL−1 10 fg·mL−1 in PBS and100 fg·mL−1 in saliva [55]
Cancer biomarkers cytokeratin 19 fragment (CYFRA21-1) and
prostate specific antigen (PSA) SiNW 1 fg·mL
−1–1 ng·mL−1
1 fg·mL−1 in buffer solution and
10 fg·mL−1 in undiluted
human serums
[47]
Prostate cancer biomarker PSA SiNW 5 fg·mL−1–500 pg·mL−1 5 fg·mL
−1 in buffer and
desalted serum
[48]
AFP and carcinoembryonic antigen (CEA) primary hepatic
carcinoma biomarkers SiNW
500 fg·mL−1–50 ng·mL−1 for AFP and
50 fg·mL−1–10 ng·mL−1 for CEA
500 fg·mL−1 for AFP and
50 fg·mL−1 for CEA [54]
Cardiac troponin I (cTnI) biomarker for acute myocardial infarction SiNW 0.092 ng·mL−1–46 ng·mL−1 0.092 ng·mL−1 [60]
Cardiac disease biomarker cTnI SiNW 5 pg·mL−1–5 ng·mL−1 5 pg·mL−1 [59]
C-reactive protein (CRP) inflammatory biomarker related with
cardiovascular diseases SWCNT 10
−4 to 102 µg·mL−1 10−4 µg·mL−1 [58]
Prostate cancer biomarker osteopontin (OPN) SWCNT 1 pg·mL−1–1 µg·mL−1 0.3 pg·mL−1 [80]
Pro-inflammatory cytokine and anti-inflammatory myokine
interleukin-6 (IL-6) SWCNT 1 pg·mL
−1–100 pg·mL−1 1.37 pg·mL−1 [81]
Stress biomarker cortisol in saliva SWCNT 1 pg·mL−1–1000 ng·mL−1 1 pg·mL−1 [82]
Lyme disease antigen SWCNT 1 ng·mL−1–3000 ng·mL−1 1 ng·mL−1 [83]
Prostate cancer biomarker OPN SWCNT 1 pg·mL−1–1 µg·mL−1 1 pg·mL−1 or 30 fM [84]
Alzheimer biomarker, amyloid-β SWCNT 10−12–10−9 g·mL−1 1 pg·mL−1 in human serum [63]
Chondroitin sulfate proteoglycan 4, multiple cancer types biomarker Graphene 0.01 fM–10 pM 0.01 fM [85]
Pancreatic cancer biomarker, carbohydrate antigen 19-9 (CA 19-9) Graphene 0.01 unit·mL−1–1000 unit·mL−1 0.01 unit·mL−1 [56]
Prostate specific antigen/α1-antichymotrypsin (PSA-ACT) complex Graphene 100 fg·mL−1–1 µg·mL−1 100 fg·mL−1 [49]
Breast cancer biomarkers human epidermal growth factor receptor 2
(HER2) and epidermal growth factor receptor (EGFR) SiO2/graphene 100 pM–1 µM
1 pM for HER2 and 100 pM
for EGFR [52]
Human immunodeficiency virus (HIV) Graphene/CPPyNP 1 pM–10 nM 1 pM [86]
Bladder cancer biomarker, urinary APOA2 protein Graphene/SiNW 19.5 pg·mL−1–1.95 mg·mL−1 6.7 pg·mL−1 [57]
Prostate cancer biomarker PSA–ACT complex Graphene/ZnO nanorods/TiO2 100 fg·mL−1–100 ng·mL−1 1 fM [87]
D-Dimer, biomarker of venous thromboembolism Graphene/TiO2 10 pg·mL−1–100 ng·mL−1 10 pg·mL
−1 in buffer and
100 pg·mL−1 in serum sample [62]
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Table 1. Cont.
Target Analyte Electroactive Nanomaterial Range Detection Limit Reference
Prostate cancer biomarker PSA MoS2 3.75 nM, 37.5 pM, and 375 fM 375 fM [51]
Prostate cancer biomarker PSA MoS2 1 pg·mL−1–10 ng·mL−1 1 pg·mL−1 [50]
Breast cancer biomarker EGFR ZnO nanofilm 10 fM–10 nM 10 fM [53]
Prostate cancer biomarker PSA Si nanobelt 50 fg·mL−1–500 pg·mL−1 5 pg·mL−1 [88]
Index for diabetes, Hemoglobin-A1c Au nanoparticles 1.67 ng·mL−1–170.5 ng·mL−1 in the order of ng·mL−1 [65]
Diabetes related hormone, insulin Si nanogratings 1 fM–1 nM 10 fM in buffer and dilutedhuman serum [64]
CRP inflammatory biomarker P3HT polymer 4 pM–2 µM 2 pM [89]
Table 2. Recent reports on immunoFET sensors based on various types of nanomaterials listed along with their application in food safety and environmental
monitoring fields.
Target Analyte Electroactive Nanomaterial Range Detection Limit Reference
Food safety
Salmonella bacteria SWCNT 103–108 CFU·mL−1 103 CFU·mL−1 [66]
Escherichia coli foodborne pathogen SWCNT 102–105 CFU·mL−1 102 CFU·mL−1 [71]
Escherichia coli O157:H7 and bacteriophage viruses SWCNT 10
3–107 CFU·mL−1 for E. coli and
102–107 PFU·mL−1 for bacteriophage
105 CFU·mL−1 for E. coli and
103 PFU·mL−1 for bacteriophage [69]
Cryptosporidium parvum intestinal parasitic protozoan Graphene 102–104 Cp. oocysts per 4 mL buffer 25 Cp. oocysts per mL buffer [73]
Escherichia coli bacteria Graphene 10–105 CFU·mL−1 10 CFU·mL−1 [70]
Escherichia coli O157:H7 bacteria Graphene 10–104 CFU·mL−1 10 CFU·mL−1 [68]
Food toxin aflatoxin B1 Graphene 10−4 ppt–1·ppt 0.1 fg·mL−1 [90]
Rotavirus Graphene 0–105 PFU·mL−1 102 PFU·mL−1 [72]
Salmonella typhimurium bacteria CeOx 2–5 × 105 cells·mL−1 2–3 cells·mL−1 [67]
Environmental monitoring
Atrazine pesticide SWCNT 0.001–10 ng·mL−1 0.001 ng·mL−1 [74]
2,4-Dichlorophenoxyacetic acid herbicides SWCNT 5 fM–500 µM 500 fM in soil sample and50 pM in buffer [75]
2,4,6-Trinitrotoluene (TNT) contamination SWCNT 0.5 ppb–5000 ppb 0.5 ppb [76]
Microcystin-LR (cyanotoxin in surface waters) SWCNT 1–1000 ng·L−1 0.6 ng·L−1 [91]
Citrus tristeza virus and Xylella fastidiosa phytopathogens InP 60–340 ng·mL
−1 for Citrus tristeza virus
and 34–250 ng·mL−1 for Xylella fastidiosa 2 nM for both phytopathogens [77]
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3.1. Silicon Nanowires
Silicon nanowires (SiNW) are semiconducting one-dimensional (1D) nanostructures with
cross-sectional diameters of nanometers and length of micrometers, which can exhibit either p-type
or n-type conductivity [92–94]. SiNW are attractive materials in FET-based biosensors design due to
their high surface-to-volume ratio, which enables the sensors ultrasensitive detection capability [95,96].
SiNW FET-based biosensors were firstly reported in 2011 by Cui et al. [97]. The authors demonstrated
that p-type boron-doped SiNW modified with biotin detected streptavidin protein down to picomolar
concentration range.
FET biosensors based on SiNW have been employed as promising clinical diagnostic platforms.
For example, Huang et al. developed a novel SiNW-FET biosensor for the detection of PSA
biomarker in human serum [48]. The SiNW were fabricated by the polysilicon sidewall spacer
technique, which is cheaper than the electron beam lithography. Figure 3a depicts top-view scanning
electron microscopy (SEM) images of such SiNW-FET devices. The SiNW surface was modified
with 3-aminopropyltriethoxysilane (APTES) to convert silanol groups into amines for glutaraldehyde
functionalization. Then, the aldehyde groups present on glutaraldehyde molecules were connected to
the amine groups to form the linker between APTES and anti-PSA antibodies. The transfer curve of
such n-type SiNW-FET sensor showed that the drain-source current (IDS) was controlled by the gate
voltage (VG) (Figure 3b). The device exhibited excellent electrical performance, and the IDS versus
drain-source voltage (VDS) depended on the applied VG (Figure 3c). Human serum was pretreated
by filtration, desalting, and buffer exchange prior to PSA detection in order to keep proper pH and
ionic strength of serum proteome. The electrical responses from the measurement of various PSA
concentrations in desalted human serum are shown in Figure 3d and the immunosensor was able to
detect PSA levels in concentrations as low as 5 fg·mL−1.
Alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) markers high expression levels
have been associated with primary hepatic carcinoma (PHC). In this context, Zhu et al. developed
SiNW-FET with polydimethylsiloxane (PDMS) microfluidic channels for the simultaneous detection of
both AFP and CEA biomarkers in desalted human serum [54]. SiNW surface was treated with APTES
and glutaraldehyde before the AFP and CEA antibodies immobilization by covalent bonding. Bovine
serum albumin (BSA) was used as a blocking agent for non-specific binding. The negatively charged
AFP and CEA enhanced the conductivity of the p-type SiNW. The dual-channel setup demonstrated the
potential use of SiNW-FET for multiple tumor markers detection in concentrations down to fg·mL−1
and ng·mL−1.
Cardiac troponin I, a very sensitive biomarker for acute myocardial infarction, was detected by a
label-free SiNW-FET biosensor [60]. Anti-cTnI antibodies were immobilized on the SiNW surfaces for
measuring the cTnI in a range of concentrations from 0.092 ng·mL−1 to 46 ng·mL−1. Higher sensitivity
of cTnI detection was reported by Kim et al. [59]. The authors demonstrated a SiNW honeycomb-like
structure for nanowire configuration. The geometry of honeycomb nanowires provided increased
surface area rather than straight nanowire configuration, improving the probability of binding events
between antigen and antibody, and enabling superior intrinsic electrical performance of biosensors.
The devices showed n-type behavior and presented LOD of 5 pg·mL−1, which was about 8-fold smaller
than the value previously reported by Kong et al. [60].
As aforementioned, the detection mechanism of FET-based biosensors is hampered in samples of
high ionic strength and efforts for bringing the antigen-antibody binding within the Debye layer have
been reported [40]. Puppo et al. got rid of the Debye screening problem by performing the electrical
measurements on dried samples after the antigen-binding coupling [98]. The authors developed
a SiNW-FET sensor for the detection of vascular endothelial growth factor (VEGF), a pathological
angiogenesis factor. Increasing concentrations of VEGF caused increase in conductance, leading to
detection in the concentration range of fM.
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3.2. Carbon Nanotubes
Carbon nanotubes are cylindrical carbon structures with diameters of nanometers and high
length/diameter ratio [99]. Multi-walled carbon nanotubes (MWCNT) consist of multiple rolled
graphite sheets [100] while single-walled carbon nanotubes (SWCNT) are single-atom rolled graphitic
layers [101,102]. Carbon nanotubes are exciting 1D materials due to their structure-dependent
electronic and mechanical properties. Their physical properties are strongly dependent on the way
that graphitic sheets are wrapped to form the tubes (chirality), causing them to ex ibit metallic or
semico ducting characteristics [99]. In particular, SWCNTs have been explor d as promising building
blocks in the construction of FET-based immunosensors with improved sensibility [58,69,76,80–82,103].
SWCNTs display high electron transfer because all carbon atoms are present in their surface.
Chemosensors 2016, 4, 20 11 of 26
In addition, SWCNTs surface can be easily modified, giving various possibilities for non-covalent and
covalent immobilization of antigens or antibodies.
For instance, Justino et al. reported an immunoFET based on SWCNT functionalized with
C-reactive protein (CRP) antibodies for detecting CRP, an inflammatory biomarker related with
cardiovascular diseases [58]. The anti-CRP antibodies were non-covalently immobilized directly
on the surface of SWCNT and the devices were capable of detecting CRP in the broad range of
concentrations from 10−4 to 102 µg·mL−1. In addition, the LOD of such devices (10−4 µg·mL−1) was
2–3 orders lower than conventional immunoassays. Sharma et al. reported a SWCNT-FET sensor
for detecting the prostate cancer biomarker osteopontin (OPN) [80]. SWCNTs were deposited on
transparent glass substrates by dielectrophoresis, allowing the direct alignment of the nanotubes
at room temperature. The SWCNT surface was treated with 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide (EDC)/N-hydroxysuccinimide (NHS). Then, the covalent immobilization of monoclonal
antibodies specific for OPN occurred through the binding with NH2 groups of NHS succinimide
ester on the SWCNTs. These devices were incubated with Tween 20 to avoid non-specific binding.
The electrical measurements showed a linear behavior after each step of functionalization of the
SWCNT-FET device, indicating a good ohmic contact between SWCNTs and source/drain electrodes.
Immunosensors exhibited a highly linear resistance change over a range of concentrations (1 pg·mL−1
to 1 µg·mL−1) of the prostate cancer biomarker OPN in human serum and PBS buffer, being 3-fold
more sensitive than the conventional ELISA immunoassay, with a LOD of 0.3 pg·mL−1.
Horizontally aligned SWCNTs grown on quartz substrates were applied as sensing platform for
measuring interleukin-6 (IL-6), a protein that acts as pro-inflammatory cytokine and anti-inflammatory
myokine [81]. The highly specific binding of the IL-6 analyte to the antibodies in the gate region caused
a change in the drain current, which was measured as an electrical signal. The devices exhibited low
detection limit (1.37 pg·mL−1), good selectivity (no responses for BSA and cysteine), and excellent
stability (no electronic degradation after storage for up to three months).
Carbon nanotubes-based FET immunosensors are also able to detect microorganisms such
as bacteria and viruses. García-Aljaro et al. reported an immunoFET based on SWCNT for the
detection of human pathogens Escherichia coli O157:H7 bacteria and bacteriophage T7 viruses [69].
The sensing platform was composed of parallel aligned SWCNTs functionalized with 1-pyrene
butanoic acid succinimidyl ester (PBASE), in which monoclonal antibodies were covalently attached.
The immunosensor exhibited a linear response for both bacteria and viruses increasing concentrations,
achieving LOD of 105 colony forming units per milliliters (CFU·mL−1) and 103 plaque forming units
per milliliter (PFU·mL−1), respectively. The biosensor showed a better performance for bacteriophage.
This result can be attributed to the decreased size and different morphology of such viruses in
comparison to bacteria, which enabled a better and faster diffusion of bacteriophage in the solution
towards the antibodies.
Small molecules, either charged or uncharged, cannot be detected by the conventional
configuration of an immunoFET, where the biorecognition event between the analyte and the
immobilized molecules takes place at the gate sensing surface. In this case, the analyte binding
does not produce a measurable conductance change because of the lack of charge or depletion in
the semiconductor channel [103]. Therefore, the displacement represents a successful strategy for
detecting such target analytes. For example, Tliti et al. described a label-free FET immunosensor
based on SWCNT for the ultrasensitive detection of stress biomarker cortisol in saliva [82]. SWCNTs
were covalently functionalized with a cortisol analog (cortisol-3-CMO-NHS ester) followed by
covalent conjugation with monoclonal anti-cortisol antibodies (large size and charged proteins).
This chemiresistive biosensor was able to detect small size and uncharged cortisol molecules because
the antibody bound to the SWCNT functionalized with cortisol analog was stripped/displaced,
provoking a large change of the device resistance/conductance and a LOD of 1 pg·mL−1 [82].
Tan et al. also fabricated a label-free immunoFET based on SWCNT by the displacement assay of
the immobilized antibodies [91]. The immunosensors were able to detect the small molecular mass
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microcystin-LR (MCRL), a toxin released by cyanobacteria in surface waters, with high sensitivity
and specificity along with a detection limit of 0.6 ng·L−1. Park and co-workers applied a SWCNT
immunoFET for the detection of a small molecule of 2,4,6-trinitrotoluene (TNT), a compound used as
ammunition/explosive [76]. It is a harmful chemical to soil and groundwater and can cause severe
environmental contaminations. The authors also employed the displacement mode/format to develop
the SWCNT-based immunosensor. The biosensor detected TNT with good selectivity and LOD of
0.5 ppb.
3.3. Graphene
Graphene consists of a honeycomb lattice of carbon atoms arranged in a two-dimensional (2D)
array in which atoms are covalently linked through sp2 hybridization. Actually, graphene is the
building block of different carbon allotropes: single layer sheets can be enrolled in carbon nanotubes,
wrapped in fullerenes, and stacked in three-dimensional graphite [104,105]. Graphene has attracted
much attention because of its remarkable properties, including high surface area (~2630 m2·g−1),
carrier mobility (~200,000 cm2·V−1·s−1), electrical conductivity (~104 S·cm−1), optical transmittance,
and Young’s modulus of ~1 TPa [106–108]. Its notable electronic and optical properties are due
to electron confinement and absence of interlayer interactions, whereas its distinct mechanical and
chemical properties are explained by geometrical effects and high surface-to-volume ratio [109].
These exceptional set of properties are particularly useful for the development of electronic sensors
with high signal-to-noise ratio. Moreover, graphene is a zero bandgap semiconductor and shows
ambipolar field-effect when incorporated in the configuration of a FET, since the Fermi level can be
modulated by the application of a voltage between graphene and the transistor source [110–112].
This 2D nanomaterial presents some advantages beyond other nanostructures in FET-based
sensors design. For example, graphene exhibits high specific surface area that can be easily
functionalized for specific interactions, and providing an increased contact area for detection.
Graphene is biocompatible, which helps to maintain the activity of antibodies; has excellent
conductivity, which enhances the electron transfer at the electrode surface, improving the sensibility;
and exhibits ambipolar characteristics [105], being able to detect both positive and negatively charged
biomolecules. Additionally, as each carbon atom of the 2D structure is directly exposed to the
environment, any biological recognition event occurring at the gate surface will generate an electrical
perturbation in the surrounding, thus improving the sensibility of the biosensor [113].
Graphene has been employed as sensing platform of FET immunosensors for detecting various
disease biomarkers. For example, Jung et al. developed a graphene FET sensor for detecting a
pancreatic cancer biomarker, carbohydrate antigen 19-9 (CA 19-9). Graphene was grown by chemical
vapor deposition (CVD) technique and transferred by a novel method to the sensor substrate, free from
remaining polymer residues. The cleaner surface resulted in higher p-doping, higher channel mobility,
and significantly enhanced sensitivity [56]. Prostate cancer biomarker, PSA/α-1-antichymotrypsin
(PSA-ACT) complex, was detected by a FET sensor based on reduced graphene oxide (RGO),
a chemically derived graphene [49]. RGO nanosheets were self-assembled on an aminated substrate
and monoclonal PSA antibodies were immobilized on this channel. Immunoreactions caused a linear
shift of gate voltage, with a LOD as low as 100 fg·mL−1.
Graphene-based FET sensors are also capable of detecting foodborne and waterborne pathogens
such as bacteria. Huang et al. demonstrated an immunosensor based on CVD graphene to detect
E. coli bacteria [70]. Graphene was deposited on a quartz substrate. Anti-E. coli antibodies were
immobilized on the graphene surface through a linker molecule (PBASE), which provided an ester
group to react with amino groups of antibodies. Non-specific binding was prevented by ethanolamine
and Tween 20 was used to passivate the uncoated regions of graphene (Figure 4a). Figure 4b
exhibits the transfer curves of the graphene-based FET sensor after each functionalization step,
demonstrating the ambipolar characteristics of graphene. Such a biosensor operating at the p-type
region exhibited a significant conductance increase after exposure to various E. coli concentrations (from
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0 to 105 CFU·mL−1) (Figure 4c). No response was triggered after exposure to Pseudomonas aeruginosa
bacteria, indicating high specificity (Figure 4d).
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Figure 4. (a) Scheme showing a graphene-based FET sensor operating in an electrolyte solution for
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surface; (b) Transfer curves (IDS × VG) of the graphene-FET sensor. Graphene exhibited ambipolar
characteristics; (c) IDS × VDS curves of graphene FET devices on various E. coli concentrations; (d) IDS
× VDS characteristics of devices after incubatio with P. aeruginosa, demonstrating high specificity of
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Chang et al. reported a graphene-based FET device to detect the most pathogenic strain of E. coli
bacteria, known as E. coli O157:H7 [68]. The authors fabricated FET devices by a solution process in
which graphene oxide nanosheets were self-assembled on the substrate and subsequently reduced by
thermal annealing. The conductance of the devices increased with increasing concentrations of E. coli
cells, achievi g a detection limit as low as 10 CFU·mL−1. Suc a d vice operated in the p-type region
and the c ndu tance incre e was induced by the highly negatively charged bacterial cells. Pathogenic
rotavirus was detected by a p-type FET biosensor based on icropatterned RGO (MRGO-FET) [72].
Specific antibodies for rotavirus were covalently immobilized all over the RGO surface. As the virus
concentration increased, the drain-source current proportionally decreased. The device was able to
detect rotavirus in a concentration as low as 102 PFU·mL−1, which is lower than the concentrations
detected by the conventional ELISA method.
The most toxic and carcinogenic food toxin, aflatoxin (AFB1), was sensitively detected by a
graphene-based FET sensor developed by Basu et al. [90]. Electrophoretically deposited RGO films
were integrated as active channel into the FET device. The high sensitivity of devices was possible
because of enhanced biom lecule immobiliz tion capability of RGO. AFB1 was detecte in the sub-fM
range, measured with a LOD of 0.1 fg·mL−1.
Okamoto et al. reported a graphene-based FET sensor that allows the antigen-antibody reaction
to occur within the electrical double layer in a buffer solution of high ionic strength [114]. Graphene
was produced through the mechanical cleavage of graphite and the monolayer’s surface was modified
with antigen-binding fragments (Fab). Fab is the binding site component of conventional antibodies
and presents a size of approximately 3 nm. Thus, it is considered that the immunoreaction may occur
inside the Debye length. Heat-shock proteins were used as target proteins to interact with Fab and
were detected with high specificity and sensitivity by the immunoFET device.
Chemosensors 2016, 4, 20 14 of 26
3.4. Molybdenum Disulfide
The 2D layered material molybdenum disulfide (MoS2) belongs to the class of transition metal
dichalcogenides and features unique optical and electronic properties that have triggered great interest
in the application of FET-based sensors [115]. The layers are held together by weak van der Waals forces
and a pristine MoS2 monolayer presents only ~0.65 nm thick [116]. Unlike graphene, a gapless material,
monolayer MoS2 exhibits a direct energy bandgap of ~1.9 eV which lowers leakage current and turns
it an emerging material for designing highly sensitive FET biosensors [51,108,117]. Furthermore, the
2D MoS2 semiconductor offers high surface-to-volume ratio, facilitating surface functionalization and
doping; high transparency, flexibility, and mechanical strength, making it an appealing material for
flexible and transparent biodevices [116].
The first demonstration of the biofunctionalization of MoS2 nanosheets for designing a
liquid-phase FET biosensor was reported by Wang et al. [51]. The authors fabricated a FET device for
real-time detection of PSA cancer biomarker. Specific antibodies for PSA protein recognition were
immobilized onto the MoS2 film surface. The n-type device conductance increased upon PSA binding
to antibody receptors. The novel immunosensor showed LOD of 375 fM as well as high selectivity,
exhibiting no response towards non-target proteins.
The detection of the same cancer biomarker was also reported by Lee et al. [50]. The team
presented a MoS2-FET biosensor that does not require a dielectric layer due to the hydrophobicity
nature of MoS2, which allows the direct adsorption of antibodies and an improved sensitivity of the
device. Figure 5a displays the schematic representation of this FET immunosensor, showing antibodies
immobilized on the MoS2 nanosheets sensing area and PSA antigen selectively bound to the antibodies.
Figure 5b exhibits the sensor response to various concentrations of PSA, which was detected with a
LOD as low as 1 pg·mL−1, a value much lower than the clinical cut-off.
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3.5. Titanium Dioxide
The biocompatibility combined with the environmentally friendly character of nanostructured
titanium dioxide (TiO2) make this material an excellent perspective interface for the development
of biosensing devices [118]. Moreover, TiO2 nanomaterial has a large specific surface area, shows
a wide bandgap energy (between 1.8 and 4.1 eV), and possesses the ability of accepting electrons,
thus the electrons resulting from the bioreceptor-analyte coupling can be gathered by TiO2 [119].
Chu et al. demonstrated a FET immunosensor based on TiO2 nanowires for the detection of rabbit
immunoglobulin G (IgG) protein [120]. Specific antibodies for rabbit IgG were encapsulated on the 1D
TiO2 surface by the electrochemical polymerization of polypyrrole propylic acid in order to immobilize
antibodies on specific regions. Biomolecules needed to be encapsulated because the material surface
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stability hinders the directly immobilization of antibodies or antigens. The target protein was detected
in the range from 119 pg·mL−1 to 5.95 ng·mL−1, with the application of a drain-source voltage of 5 V.
3.6. Zinc Oxide
Nanostructured zinc oxide (ZnO) is a semiconductor with a wide bandgap energy of 3.37 eV [121].
ZnO is a suitable material for biosensing applications due to its biocompatibility with low toxicity
to humans and a high isoelectric point. It has been explored in the detection of enzymes, antibodies,
DNA, etc. [122,123]. Recently, a highly sensitive and selective FET immunosensor based on ZnO was
reported [53]. A thin ZnO nanofilm (50 nm thick) was grown onto the gate region to act as an n-type
channel and monoclonal antibodies were biofunctionalized on it. The drain current increased as a
function of the antigen concentration increase and EGFR, a biomarker overexpressed by breast cancer
tumors, was detected with a LOD as low as 10 fM.
3.7. Hybrid Nanomaterials
The performance of FET-based biosensors can be tuned by incorporating other nanomaterials
(metal, oxides and semiconductor nanoparticles) on the nanostructured channel to obtain a hybrid
structure. Nanoparticles-based hybrid nanomaterials have gaining significant attention because they
offer the possibility to combine the individual properties in one material, resulting in a novel material
that may exhibit synergistic properties, contributing to improve the selectivity and sensitivity of
biosensors [24,31].
The presence of nanoparticles on the nanomaterial surface increases the specific surface area,
providing an even larger surface for recognizing an analyte, thus resulting in amplified signal
transduction response and higher conductivity. The improved sensitivity of these hybrid-based
sensors is also associated with increased interfacial capacitance caused by the capacitive coupling
between the nanoparticles and the nanomaterial platform [124]. For instance, Mao et al. demonstrated
the electrical protein binding detection by an immunosensor based on MWCNT decorated with
gold nanoparticles-antibody conjugates [125]. The gold nanoparticles labeled with anti-horseradish
antibodies were attached onto MWCNT surface through non-covalent binding. Biological recognition
events between antibodies and horseradish peroxidase antigens caused changes in the drain current
and proteins were found to be accurately detected in the order of 1 fM.
In a further work, Mao and co-workers reported the first highly sensitive and selective FET-based
biosensor using RGO decorated with gold nanoparticles-antibody conjugates for protein detection
(Figure 6a). Gold nanoparticles of 20 nm average size conjugated with IgG antibodies were immobilized
on a thermally obtained RGO surface. The binding event of recognizing IgG target induced significant
changes in electrical measurements of the device, achieving a detection limit as low as 2 ng·mL−1 [126].
In another effort to develop a new method to design a FET graphene-hybrid biosensor, the same
research team switched the RGO sensing platform to vertically-oriented graphene sheets which were
directly grown on the substrate (Figure 6b). Graphene was also functionalized with gold nanoparticles
conjugated with antibodies and the devices were able to detect IgG protein again with high sensitivity
(down to 2 ng·mL−1) [127].
Hybrid sensors have a great potential to detect a wide variety of proteins for disease diagnosis.
In this direction, Myung et al. demonstrated a novel FET immunosensor based on RGO encapsulated
nanoparticle for detecting breast cancer biomarker [52]. Graphene oxide layers enwrapped silicon
oxide nanoparticles functionalized with APTES by electrostatic interactions. Then, the hybrid
graphene-nanoparticles were assembled at the gate region and specific monoclonal antibodies for
human epidermal growth factor receptor 2 (HER2) and EGFR protein biomarkers were immobilized on
its surface. The p-type device presented a decrease in conductance upon biomolecule target binding,
with LOD of 1 pM for HER2 and 100 pM for EGFR. Kwon et al. fabricated a FET immunosensor for
human immunodeficiency virus (HIV) detection using graphene-conducting polymer nanoparticle
arrays nanohybrids [86]. The close-packed carboxylated polypyrrole nanoparticles (CPPyNP) of
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approximately 20 nm in size increased the surface area, resulting in a synergistic effect. The biomarker
HIV-2 gp36 antigen (HIV-2 Ag) was covalently anchored to the nanoparticles surface and allowed HIV
antibodies recognition in a concentration as low as 1 pM.
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Zhang and co-workers developed a renewable FET immunosensor based on a graphene-TiO2
hybrid for detection of D-Dimer, a venous thromboembolism biomarker [62]. The FET device was
fabricated by assembling a nanocomposite of RGO functionalized with TiO2 nanoparticles (TiO2@RGO)
onto a RGO surface in order to form a sandwich architecture on the sensing channel. The biodevice
was capable of detecting the D-Dimer biomarker with excellent sensibility and specificity, achieving
LOD of 10 pg·mL−1 in PBS buffer and 100 pg·mL−1 in serum, respectively. The reusability of the
hybrid immunosensor was performed by irradiation of ultraviolet light to photocatalytically clean the
organic mol cules on the urface.
3.8. Other Nanomaterials/Other Reports of Interest
Starodub et al. fabricated a FET immunosensor based on CeOx as the gate surface to detect
Salmonella typhimurium, a bacterium that causes food poisoning [67]. Thin CeOx layers were deposited
on the gate region by electron beam evaporation. S. typhimurium was detected with sensitivity of
2–3 cells·mL−1. The overall time of analysis was reduced from 30 min to 15–20 min by immobilizing
specific antibodies labeled with horseradish peroxidase enzymes onto the gate surface, without
altering the device sensitivity. Moreover, the devices were found to be reusable for up to five times
without signal decrease by simply treating them with an acidic solution for the destruction of the
antigen- ntibody bindings.
Wu et al. proposed a FET sensor based on silicon nanobelt to detect prost te cancer b omarkers [88].
The n-type Si nanobelt immunoFET device was fabricated by functionalizing the nanobelt surface
with APTES, glutaraldehyde, and antibodies specific for PSA recognition. The authors observed a
decrease in drain current as a function of increasing PSA concentration, achieving a LOD of 5 pg·mL−1.
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The sensitivity of the device was enhanced by introducing arginine molecules between APTES and
glutaraldehyde, providing a more effective space region for antigen binding, and PSA was detected in
concentration levels as low as 50 fg·mL−1.
A FET immunosensor based on gold nanoparticles capped with self-assembled monolayers (SAM)
of alkanethiol molecules deposited onto a gold surface was fabricated for detecting hemoglobin-A1c
(HbA1c), an important index for diabetes [65]. HbA1c antibodies were stably immobilized on SAM
by the end functional groups of thiols. Gold nanoparticles played an important role in the sensor’s
sensitivity because they possess high surface-to-volume ratio, thus offering more sites to immobilize
biomolecules. The immuno device was capable of detecting the antigen in concentrations in the order
of ng·mL−1.
Conventional FET sensors based on SiNW exhibit very low LOD, however they suffer from
device instability, device-to-device variations, and discrete dopant fluctuations. An alternative to
these drawbacks was demonstrated by using silicon nanogratings (SiNG) rather than SiNW [64].
The SiNG devices were fabricated using p-doped silicon-on-insulator substrates that were subjected to
etching steps, thermal surface oxidation, and annealing. The biodevices presented higher electrical
stability and reproducibility when exposed to buffer solution, being capable of detecting insulin,
a diabetes-related hormone, with LOD down to 10 fM, both in buffer and diluted human serum.
C-reactive protein was ultrasensitively detected by a FET immunosensor based on an organic
semiconductor surface composed of poly-3-hexyl thiophene (P3HT) [89]. Monoclonal anti-CRP
antibodies were immobilized by physical adsorption onto the gate without any previous surface
treatment. The transfer characteristics of the immunosensor showed a reduction in current with
increasing concentrations of CRP and a LOD of 2 pM.
Multiplexed FET immunosensors are able to give insights on differential diagnosis. For instance,
Cheng et al. reported a multianalyte immunoFET capable of detecting two lung cancer tumor
markers [128]. Both cytokeratin 19 fragments (CYFRA21-1) and neuron-specific enolase (NSE) were
quantitatively detected at the same time. The microdevice was fabricated through two FET integrated
on the same chip and each transistor gate was biofunctionalized with different specific antibodies.
CYFRA21-1 and NSE were detected with LOD of 1 and 100 ng·mL−1, respectively. These results
suggest a potential to easily identify different lung cancer types.
Label-free FET sensing also plays an important role on the early infection detection of agriculture
plagues. Citrus tristeza virus and Xylella fastidiosa bacterium were detected by a FET biosensor using
n-type indium phosphide (InP) as a biosensing platform [77]. InP substrate was aminated and PEGylated
prior to the antibodies immobilization. The immunoFET detected phytopathogens with sensitivity of
2 nM, this value being comparable with highly sensitive biosensing electrochemical approaches.
4. Aptamers Instead of Antibodies
Aptamers consist of artificial oligonucleotide sequences (peptides or nucleic acids) which can
recognize and bind to a wide range of targets including amino acids, proteins, enzymes, peptides,
metal ions, small chemicals, viruses, and even cells with remarkable specificity and affinity [129].
Aptamers are produced through the in vitro selection and amplification of populations of random
sequence oligonucleotide libraries, known as the SELEX process (selection evolution of ligands by
exponential enrichment) [130].
This new class of synthetic molecules was first reported in 1990 [130,131]. Aptamers are known
as antibody mimics and they have drawn much attention as promising alternatives to conventional
antibodies in the design of novel FET-based immunosensors. Aptamers are capable of offering some
advantages over antibodies: as they are synthetic molecules, they are chemically produced with high
accuracy and reproducibility, without the use of animals or cell cultures; their production is less
expensive and time-consuming than the whole process to generate specific monoclonal antibodies; and
they exhibit high chemical stability in several buffer conditions, without losing bioactivity [129,132,133].
The greatest advantage of using aptamers instead of antibodies is their small size (approximately
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1–2 nm), a property that makes them shorter than the Debye length. Therefore, the biorecognition
event between the target analyte and the aptamer may occur within the electrical double layer, even in
physiological solutions of high ionic strength, resulting in improved sensitivity and a broader range of
analytes [134].
Recently, various FET-based immunosensors using aptamers immobilized on nanomaterial
sensing channels were reported [135–143]. For instance, So et al. firstly demonstrated a FET biosensor
based on SWCNT using aptamers as bioreceptors. Thrombin aptamers were covalently immobilized
onto the surface of SWCNT previously treated with carbodiimidazole-activated Tween 20 (CDI-Tween).
The SWCNT-FET sensor presented a conductance decrease upon aptamer-target binding, being able to
detect thrombin, a coagulation protein, with a LOD of 10 ng·mL−1 [140]. Maehashi et al. fabricated a
SWCNT-FET immunosensor for immunoglobulin E (IgE) detection [137]. IgE is a protein overexpressed
by individuals with immune deficiency diseases. SWCNT channel was covalently modified with
anti-IgE aptamers using PBASE as a linker molecule. The presence of IgE caused a sharp decrease
in the drain-source current, indicating that the recognition event occurred inside the Debye layer.
The dissociation constant for the reactions between aptamers and IgE was found to be 1.9 × 10−9 M.
Ohno et al. reported the detection of the same protein (IgE) by a graphene-FET immunosensor [138].
Anti-IgE aptamer DNA oligonucleotides of approximately 3 nm in size were covalently immobilized
on the graphene channel surface through a linker molecule (PBASE). The drain current was found to
be directly dependent on the IgE concentration and a dissociation constant of 47 nM was estimated.
FET sensors using aptamers have been employed for the detection of disease biomarkers.
For example, the detection of VEGF for cancer diagnosis was demonstrated by a SiNW-FET sensor
modified with VEGF RNA aptamers [136]. Charged VEGF molecules on the surface of SiNW acted as
electrically positive point-charges in both p-type and n-type SiNW-FET sensors. They were detected
with LOD of 1.04 nM and 104 pM for n-type and p-type SiNW-FET, respectively. Interferon-gamma
(IFN-γ) can be used as a biomarker to diagnose infectious diseases like tuberculosis [135]. This cytokine
was sensitively detected through a graphene-FET immunosensor using IFN-γ DNA aptamers
immobilized on the graphene surface. The binding of IFN-γ caused an increase in current across
the graphene channel with increasing concentrations of IFN-γ, achieving LOD as low as 83 pM.
Abnormal levels of CEA tumor marker were detected by a FET sensor fabricated using carboxylated
polypyrrole multidimensional nanotubes (C-PPy MNTs) conjugated with CEA-binding aptamers [139].
The FET-aptasensor presented a p-type behavior since the drain-source current increased with the
application of negative gate voltages. CEA was ultrasensitively detected, with a LOD of 1 fg·mL−1,
being a value 2–3-fold lower than those previously reported.
Aptamer-based sensors are able to directly detect small molecules and weakly charged analytes.
For example, Wang et al. reported a graphene–FET device to detect the small molecule steroid hormone
dehydroepiandrosterone sulfate (DHEA-S) [141]. The sensing surface was prepared by anchoring
a short DNA sequence complementary to the aptamer onto the graphene surface, thus forming an
aptamer–DNA anchor hybrid layer. The analyte (DHEA-S)-aptamer binding changes the aptamer
conformation, releasing the aptamer from the graphene surface, and consequently inducing changes
in graphene conductance. DHEA-S biomarker was detected with high specificity, achieving a clinically
relevant detection limit (44.7 nM). Their findings demonstrate the potential of an aptamer-based FET
sensor to detect other important low-charged small molecules in the biomedical field.
5. Conclusions and Future Perspectives
This review presents recent trends on FET-based immunosensors for the label-free detection
of a broad range of analytes. The most recent reports have demonstrated a growing interest on
the application of various nanomaterials such as silicon nanowires, carbon nanotubes, graphene,
molybdenum disulfide, and others as sensing channels of FET-based devices. Nanostructured
materials exhibit excellent physicochemical properties including high specific surface area and chemical
stability, which make them attractive platforms for immobilizing specific antibodies to design novel
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FET immunosensors with improved specificity and sensitivity. These nanomaterials-based FET
immunosensors have shown very low detection limits towards biomolecules such as protein disease
biomarkers, pathogenic microorganisms like bacteria and viruses, and environmental pollutants like
toxins, pesticides, and herbicides.
The detection of analytes in low ionic strength buffers and desalted serum by FET immunosensors
has been described. However, the direct detection of antigen-antibody reactions in physiological
solutions without sample pretreatment has proven to be a challenging undertaking. Therefore, the use
of aptamers instead of antibodies has been reported as an alternative to bring the biorecognition event
within the electrical double layer even under high ionic strength conditions.
In summary, research regarding FET-based immuno devices appreciably increased in the last
years, demonstrating countless opportunities to explore these biosensors as promising alternatives to
conventional immunoassays, especially for the early-stage detection of disease biomarkers. The use of
nanomaterials as sensing channels enables the design of immunosensors with enhanced performance,
opening new prospects in the development of highly sensitive, miniaturized, and unlabeled immuno
devices for PoC applications and simultaneous multiplexed immunoassays.
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APTES 3-aminopropyltriethoxysilane
BSA bovine serum albumin
CA 19-9 carbohydrate antigen 19-9
CDR complementarity determining regions
CEA carcinoembryonic antigen
CeOx cerium oxide
CPPyNP carboxylated polypirrole nanoparticles
CRP C-reactive protein
cTnI cardiac troponin I
CVD chemical vapor deposition
CYFRA21-1 cytokeratin 19 fragments
DHEA-S dehydroepiandrosterone sulfate
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EGFR epidermal growth factor receptor
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FET field-effect transistor
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HBsAg hepatitis B marker
HIV human immunodeficiency virus
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IFN-γ interferon-gamma
IgE immunoglobulin E
IgG immunoglobulin G
IL-6 interleukin-6
IL-8 interleukin-8
ISFET ion-sensitive field effect transistor
LOD limit of detection
MCRL microcystin-LR
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MoS2 molybdenum disulfide
MWCNT multi-walled carbon nanotubes
NHS N-hydroxysuccinimide
NSE neuron-specific enolase
OPN osteopontin
P3HT poly-3-hexyl thiophene
PBASE 1-pyrene butanoic acid succinimidyl ester
PBS phosphate-buffered saline
PDMS polydimethylsiloxane
PoC point-of-care
PSA prostate specific antigen
PSA-ACT Prostate specific antigen/α1-antichymotrypsin
RIA radioimmunoassay
RGO reduced graphene oxide
SAM self-assembled monolayers
SELEX selection evolution of ligands by exponential enrichment
SEM scanning electron microscopy
SiNG silicon nanogratings
SiNW silicon nanowire
SWCNT single-walled carbon nanotubes
TiO2 titanium dioxide
TNF-α tumor necrosis factor α
TNT 2,4,6-trinitrotoluene
VDS drain-source voltage
VEGF vascular endothelial growth factor
VG gate voltage
ZnO zinc oxide
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